Cargando…
Advances of Tumorigenesis, Diagnosis at Early Stage, and Cellular Immunotherapy in Gastrointestinal Malignancies
Globally, in 2018, 4.8 million new patients have a diagnosis of gastrointestinal (GI) cancers, while 3.4 million people died of such disorders. GI malignancies are tightly relevant to 26% of the world-wide cancer incidence and occupies 35% of all cancer-associated deaths. In this article, we princip...
Autores principales: | Zhu, Haipeng, Liu, Xiaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381364/ https://www.ncbi.nlm.nih.gov/pubmed/34434889 http://dx.doi.org/10.3389/fonc.2021.666340 |
Ejemplares similares
-
The immunotherapy advancement targeting malignant blastomas in early childhood
por: Zang, Bolun, et al.
Publicado: (2023) -
Editorial: Advances in the Molecular Mechanisms in Gastrointestinal Tumorigenesis and Treatment
por: Zhang, Ruowen, et al.
Publicado: (2022) -
Current understanding of cancer stem cells: Immune evasion and targeted immunotherapy in gastrointestinal malignancies
por: An, Junyi, et al.
Publicado: (2023) -
Cellular Immunotherapy and Locoregional Administration of CAR T-Cells in Malignant Pleural Mesothelioma
por: Belderbos, Robert A., et al.
Publicado: (2020) -
Critical roles of PTPN family members regulated by non-coding RNAs in tumorigenesis and immunotherapy
por: Tang, Xiaolong, et al.
Publicado: (2022)